Imazio Massimo
Cardiology Department, Maria Vittoria Hospital, Torino, Italy.
J Atr Fibrillation. 2012 Aug 20;5(2):608. doi: 10.4022/jafib.608. eCollection 2012 Aug-Sep.
Drugs to alter or delay myocardial remodelling associated with heart failure, hypertension, or inflammation in the post-operative setting, may prevent the development of atrial fibrillation. Current experimental and clinical evidences support specific treatments for defined patient population (i.e. ACE-inhibitors and ARB for chronic heart failure and hypertension expecially with LV hypertrophy; statins, corticosteroids and possibly colchicine after cardiac surgery).
在术后环境中,用于改变或延缓与心力衰竭、高血压或炎症相关的心肌重塑的药物,可能会预防房颤的发生。目前的实验和临床证据支持针对特定患者群体的特定治疗方法(即用于慢性心力衰竭和高血压尤其是伴有左心室肥厚的患者的ACE抑制剂和ARB;心脏手术后使用他汀类药物、皮质类固醇以及可能的秋水仙碱)。